You just read:

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

News provided by

Locus Biosciences Inc.

Jan 03, 2019, 09:00 ET